T he desire to obtain a definitive diagnosis to optimize medical treatment has increased the demand for early, more invasive, and costly investigative procedures. Open lung biopsy is regarded as the gold standard for the diagnosis of pulmonary infiltrates, and several studies have documented its use in specific patient populations. [1] [2] [3] A complete history, physical examination, chest radiography, sputum cytology, and cultures will provide a reliable diagnosis in about 30% of patients. 4 Fiberoptic bronchoscopic investigations provide a diagnosis in 38% to 85% of patients according to the classification of histological findings. 5 In comparison, the reported diagnostic yield of open lung biopsy ranges from 80% to 94%. 5 The decision for an open lung biopsy in critically ill patients is based on the need to make a specific diagnosis, and thereby direct specific treatment, withhold potentially ineffectual and/or harmful empirical treatment, or provide important prognostic information.
Because the relative risk of the procedure must be balanced by the net benefit for the patient, accurate information about the clinical utility of the open lung biopsy in critically ill patients is essential. In predominately noncritically ill patients the clinical utility of the open lung biopsy remains controversial as to whether it does, 6, 7 or does not, 2, 8, 9 influence mortality for those in whom a specific diagnosis is made.
The aim of this study was to determine the diagnostic yield, morbidity, mortality, and influence on subsequent treatment of open lung biopsy in patients with ventilator-dependent respiratory failure associated with bilateral pulmonary infiltrates.
Materials and Methods
A retrospective review was conducted of medical case records of patients admitted to an adult university-affiliated tertiary referral ICU during the period of 1985 to 1995. Inclusion criteria were patients with ventilator-dependent respiratory failure and nonspecific radiological pulmonary interstitial infiltrates who had undergone open lung biopsy. This included patients already receiving mechanical ventilation and those admitted to the ICU for mechanical ventilation. Patients who had therapeutic thoracotomies and incidental open lung biopsy were excluded. Ethical approval for this study was granted by the Royal Adelaide Hospital Human Ethics Committee.
The information obtained included the following: demographic data, data taken before (Table 1 ) and after ( The extent of organ failure, other than respiratory, at the time leading up to open lung biopsy was determined based on previously established criteria defined in Table 3 . 10 Immunosuppression was defined as a blood white-cell count of Ͻ 500/mm 3 or the use of steroids for longer than 7 days. The open lung biopsies were performed in an operating theater under general anesthesia. Access to the lung was via an anterior mini-thoracotomy. Sampling sites were selected based on radiologically affected sites and/or the lingula. A maximum of two tissue samples were obtained. All patients had one or two underwater seal drains in situ postoperatively. All operative lung samples were sent for Gram's staining and bacteriological, virological, and histological analysis. Sampling sites were not used as a variable for analysis, because those sites sampled had been well documented in terms of their efficacy. 11, 12 Statistical analysis of the data was carried out using descriptive statistics for the ratio data and the 2 test for nominal data and non-normally distributed data. Mean, SD, and 95% confidence intervals (CIs) were determined. Analysis was performed by the computerized statistical software package Minitab v 8 (Minitab Inc; Philadelphia, PA).
Results
Open lung biopsy was an infrequently performed procedure with a yearly incidence of 0 to 0.9% of patient admissions to the ICU. Twenty-four patients were identified who fulfilled the study criteria. The mean age (Ϯ SD) was 48.9 Ϯ 16.1 years.
All patients were receiving antimicrobial medications before the open lung biopsy. Seventeen patients (71%) were immunosuppressed at the time of the open lung biopsy. The median number of other Table 2 .
The time course, starting with hospital admission, fiberoptic investigation, then open lung biopsy, and discharge from ICU for survivors and nonsurvivors, did not differ and is illustrated in Figure 2 . Three patients (13%) did not have a fiberoptic bronchoscopy as part of their respiratory diagnostic work-up. All three patients were in the nonsurvivor group.
Of the patient characteristics examined, the number of other organs involved was the only statistically significant feature to differentiate between survivors and nonsurvivors. Figure 3 shows the number of other organ failures and the associated causes of death. No patient with Ն 2 other organ failures survived, despite the results of the open lung biopsy. Multisystem organ failure (MSOF) was the predominant cause of death in those patients with a greater number of other organ dysfunctions.
Five patients (21%) had documented intraoperative complications. Four patients had documented hypoxia (defined as arterial oxygen saturation Ͻ 90%), and one patient had hypotension requiring the introduction of inotropes.
Postoperative complications occurred in 17% of the subjects. All such patients had persistent air leaks. One also had excessive postoperative bleeding, requiring an emergency reoperation for hemorrhage control; soon after, the patient died in ICU from irreversible shock. One patient died on the 5th postoperative day while on positive pressure ventila- tion from a tension pneumothorax on the side of the thoracotomy for the open lung biopsy.
Open lung biopsy provided a specific diagnosis in 46% and a nonspecific diagnosis in 46% of the patients. Five patients, in whom a previous fiberoptic bronchoscopy had shown what was considered to be a specific pathogenic organism, had nonspecific findings on biopsy. A nonspecific histological finding was considered to be one showing various stages of an acute lung injury. Two patients, who had received bleomycin 2 and 3 weeks before presentation, were thought to have histological evidence for drugrelated lung injury.
Histology was interpreted as normal in two patients (8.3%). In one of these patients, subsequent histology at autopsy, 3 days later, confirmed desquamative interstitial pneumonitis. The other patient had aspergillus pneumonia that was diagnosed 3 weeks after the open lung biopsy and a high-resolution CT scan of the chest suggestive of bronchiolitis obliterans. The latter patient was not considered as an open lung biopsy misdiagnosis in this study.
Open lung biopsy findings directed a change of therapy for 18 patients (75%). Seven patients (29%) had a histologically based replacement of their antimicrobial therapy. Table 4 shows the open lung biopsy diagnosis, the open lung biopsy specific treatment, and corresponding cause of death.
Discussion
Open lung biopsy established a specific diagnosis in 46% of the patients in this series, all of whom were critically ill and with ventilator-dependent respira- Open lung biopsy findings may have contributed positively to the outcome of survivors from the nonspecific diagnosis group who subsequently received steroid therapy, as has been suggested elsewhere. 10, 13 The effect of the timing of an open lung biopsy, in relation to the patients' illness and eventual outcome, is not clearly defined. Rossiter et al 9 15 reviewed 10 studies performed before 1983. The range for a specific diagnosis is 55% to 95%, but the definitions differ among the various studies. In their own study, using criteria for histological diagnosis that are similar to those used in this study, a specific diagnosis was found in 71% of the patients compared to 46% in this study. All or a large proportion of these patients were not receiving mechanical ventilation, which itself can result in lung injury and abnormal histological changes. 16, 17 The error rate in this study was 4%. This error rate compares with rates of 12%, 18 3.4%, 2 and 3% 9 that have been found elsewhere.
Canver and Mentzer 19 looked specifically at ventilator-dependent patients with diffuse idiopathic lung disease. They included interstitial pneumonitis and fibrosis as well as alveolitis as a specific diagnosis, thus recording a 100% specific diagnosis rate. A change in therapy was initiated in 67% of patients, a rate similar to the one used in this study. Overall mortality was 52%, which is lower than the overall mortality rate of 67% in our study. Other hospital mortality rates after open lung biopsy have been reported as 63%, 18 45%, 9 and 52%. 2 Gender, age, number of ventilatory days before open lung biopsy and after biopsy treatment, as in this study, did not influence survival. Associated illnesses, which were not quantified by Canver and Mentzer, 19 did not influence survival, unlike the findings of this study.
Operative mortality and morbidity have been reported, respectively, as 0% and 9.6%, 9 1.5% and 22%, 18 and 1.6% and 48%. 2 These rates appear to be higher in ventilated patients. Operative mortality in the series of ventilator-dependent patients studied by Canver and Mentzer 19 was not recorded, but a complication rate of 40% was documented. This rate was twice the rate found in our study. The open lung biopsy-related mortality rate for our patient population was 8.4%. All patients were severely ill with dysfunction in Ն 2 other organs. Based on the results of this study, these patients would not have been expected to survive, otherwise, because no patients with a similar number of organ dysfunctions survived.
The requirement for mechanical ventilation within the first 72 h of admission has been associated with increased mortality. 20 The mortality in this group of patients, all of whom had respiratory failure requiring mechanical ventilation, is much greater than that seen in other groups of patients, predominately those not receiving mechanical ventilation. This suggests that the need for mechanical ventilation leading up to or immediately after an open lung biopsy is predictive of increased mortality.
The initial management of patients with acute pulmonary infiltrates and respiratory failure is an area of much deliberation within the environment of the ICU. Patients are often treated with empirical antimicrobial medications. These may be added in the setting of existing corticosteroid and/or other immunosuppressive medications. 18, 21, 22 The open lung biopsy can direct the withdrawal of otherwise empirical therapy and provide a basis for limiting prolonged and otherwise unnecessary intensive care therapy. The expected withdrawal-of-therapy rate after an open lung biopsy would depend greatly on the group of patients examined. Hiatt et al 18 determined that 62% of their study group of immunosuppressed patients with predominantly hematological malignancies had nontreatable disease. While studying a group of patients with diffuse pulmonary infiltrates and acute respiratory failure (25% of whom required mechanical ventilation), Warner et al 23 found an open lung biopsy withdrawal-of-therapy rate of 7.5%, a rate comparable to the 8.4% of all patients in this current study.
As an investigative tool in critically ill patients, the open lung biopsy is an infrequently performed procedure with a maximal yearly incidence of 0.9% during the time period for this study. This low incidence limits the power of such a study, as do any confounding factors that may have developed during that time frame. However, this number is similar to other studies that have documented 20 23 and 31 20 patients with respiratory failure requiring mechanical ventilation in a 10-year period, although one study involved 27 such patients 19 in a 6-year period.
Haverkos et al 2 studied 59 patients in ICU (need for mechanical ventilation not stated) over an 8.5-year time frame. In the latter study, there was an increase in the proportion of patients who were not immunosuppressed and undergoing an open lung biopsy. There was no identifiable trend for the use of an open lung biopsy in our study.
In conclusion, this retrospective 10-year study of patients in the ICU with undiagnosed diffuse pulmonary infiltrates requiring mechanical ventilation showed that an open lung biopsy can provide a specific diagnosis in at least 46% of cases. Of the patients with a specific diagnosis, in whom the open lung biopsy guided a specific therapeutic alteration, 36% survived until discharge from the hospital. The biopsy also led to the withdrawal of therapy in another 9% of this group. Mortality and morbidity rates associated with open lung biopsy in this and one other study of mechanically ventilated patients were higher than in the studies involving nonventilated patients. Thus, the careful selection of patients for open lung biopsy is crucial in overall clinical use and whether the patient will benefit from this procedure should be considered. Generally, as indicated by this study, patients with respiratory failure requiring mechanical ventilation with a higher multiple organ dysfunction score (MODS) tend to die from MSOF despite the open lung biopsy histological findings and open lung biopsy-directed therapeutic alterations.
